Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET.
Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma, and health tech leaders. This week, STAT’s Helen Branswell will be sitting down with Nancy Messonnier, senior official for the Covid-19 Vaccine Task Force at the Centers for Disease Control and Prevention, to continue the discussion on the status of the Covid-19 vaccine rollout. They will discuss updates on this ongoing process, successes and challenges, and of course, will be taking your questions live.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
"continued" - Google News
January 05, 2021 at 10:10PM
https://ift.tt/392wsv5
STAT+ Conversations: A (continued) chat on the Covid-19 vaccine rollout - STAT
"continued" - Google News
https://ift.tt/2WiTaZN
https://ift.tt/2YquBwx
Bagikan Berita Ini
0 Response to "STAT+ Conversations: A (continued) chat on the Covid-19 vaccine rollout - STAT"
Post a Comment